GIB is actively involved in ACGT (Advancing Clinico-Genomic Trials on Cancer), a project funded by the European Commission to develop new methods and tools for clinical trials in the after genome age. 25 partners from 13 countries participates in the project, in which we have led research into new models of databases and the semantic interoperability of clinical databases, microarray and images. As a result of this work has been a semantic mediator and a cancer ontology.
Years after working on ACGT (Advanced Clinic-Genomic Trials on cancer), the objective of our FP7 INTEGRATE and EURECA projects is to advance research in oncology through a unique accessible biomedical infrastructure integrating diverse datasets, building predictive bionetworks and offering advanced tools to guide diagnosis and therapeutics. Based on multi-centric clinical trials programmes on breast cancer and other oncology domains, those projects exploit a collaborative environment to combine multi-scale biomarkers (from genetic level to tissue level including imaging biomarkers) to define a methodology to improve the prognostic power of practices for assessing modern therapies in cancer treatment. Working together with partners such as Philips and various leading oncology centers from Europe, we aim to develop a new framework for future clinical trials.
Related Projects
InSite is a platform to enable the trustworthy re-use of Electronic Health Records (EHR) data for clinical research. InSite offers an integrated view of heterogeneous clinical data sources through easy to use applications. More...
Achieving semantic interoperability among EHR and clinical trial systems is at the core of the project, as it is the basis for enabling many of the software services and tools. More...
INTEGRATE aims to build solutions that support a large and multidisciplinary biomedical community to collaborate, share ... More...
The completion of the Human Genome Project sparked the development of many new tools for today’s biomedical researcher to use in finding the mechanism behind disease. More...
In p-medicine 19 partners from 9 European countries and Japan have dedicated themselves to create support and sustain new knowledge and technologies to overcome current problems in clinical research. More...
The main objective of the project is the creation of centres of excellence to promote health research, education and practice in Africa. The creation of these centres will be based on four main pillars: e-learning, knowledge sharing, "know-how" and information technologies. More...
“Tratamiento 2.0” is a project lead by the enterprise INDRA in which take part the Biomedical Informatics Group (GIB). More...
Related News
David Rubio y David Pérez del Grupo de Informática Biomédica presentan su trabajo en LOINC Conference 2022
Professor Victor Maojo, AFRICA BUILD Coordinator, exchanging views with two ministers from Cameroon
AFRICA BUILD Portal: Connecting Health Researchers in Africa
New Communities of Practice at the AFRICA BUILD Portal
AFRICA BUILD Symposium at Eldoret (Kenya)
AFRICA BUILD 1st International Conference
Victor Maojo discussed at Jimenez Diaz Foundation on innovation in medical informatics
AFRICA BUILD Consortium at HELINA 2013
